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ABSTRACT  
Objective: To investigate the association between caffeine consumption and cognitive 
outcomes in later life. Methods: Participants were 923 healthy adults aged about 70 years in 
the Lothian Birth Cohort 1936 Study, on whom there were IQ data from age 11 years. 
Cognitive function at age 70 was assessed using a battery of tests measuring general cognitive 
ability, speed of information processing, and memory. Current caffeine consumption (using 
multiple measures of tea, coffee and total dietary caffeine) was obtained by self-report 
questionnaire, and demographic and health information was collected in a standardized 
interview. Results: In age- and sex-adjusted models there were significant positive 
associations between total caffeine intake and general cognitive ability and memory. After 
additional adjustment for age 11 IQ and social class—individually and together—most of 
these associations became non-significant. A robust positive association, however, was found 
between drinking ground coffee (e.g. filter and espresso) and performance on the National 
Adult Reading Test (NART, p = .007), and the Wechsler Test of Adult Reading (WTAR, p = 
.02). No gender effects were observed, contrary to previous studies. Generally, higher 
cognitive scores were associated with coffee consumption, and lower cognitive scores with 
tea consumption, but these effects were not significant in the fully adjusted model. 
Conclusions: The present study is rare in having childhood IQ in a large sample of older 
people. The results suggest that the significant caffeine intake-cognitive ability associations 
are bidirectional—because childhood IQ and estimated prior IQ are associated with the type 
of caffeine intake in old age—and partly confounded by social class. Key words: caffeine, 
cognitive function, childhood IQ, aging.  
 
BMI = Body mass index; FFQ = Food Frequency Questionnaire; M = mean; MHT = Moray 
House Test; PCA = Principal Components Analysis; SD = standard deviation; SMS1947 = 
Scottish Mental Survey 1947; LBC1936 = Lothian Birth Cohort 1936; SES = socio-economic 
status 
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INTRODUCTION 
By late adulthood, people typically experience some deterioration in cognitive abilities as part 
of the normal course of aging. Abilities such as memory, reasoning, and processing speed all 
decline, on average, with age (1). However, there are large individual differences in age-
related cognitive changes and it is a research priority to identify factors that affect the rate of 
age-related cognitive decline. In the setting of an increasingly aged population, such 
knowledge can improve the health and wellbeing of older people in the future (2). 
 
There is growing evidence from epidemiological studies that caffeine consumption is 
associated with better cognitive performance in later life. Caffeine is widely consumed in 
Western societies, primarily in coffee and tea but also in chocolate and carbonated drinks. It 
acts as a psychoactive stimulant and has been shown to improve cognitive performance in the 
short term (3). By increasing the activity of the central nervous system, caffeine consumption 
can result in heightened alertness, vigilance, attention and mood as well as improved 
complex, higher cognitive functions, including memory (4, 5). Besides these short-term 
effects, there is also a growing body of evidence from studies indicating that the habitual 
consumption of coffee and tea has long-term beneficial effects on brain function (6). Using 
data from the Health and Lifestyle Survey (HALS), a large cross-sectional study of 9003 
British adults, Jarvis (7) reported a dose-response trend between habitual tea and coffee 
consumption and cognitive performance in all four tasks measured: simple reaction times, 
choice reaction times, incidental verbal memory, and visuospatial reasoning. Interestingly, the 
oldest men and women appeared to benefit most from a higher caffeine intake.  
 
One possible explanation, underlying the positive association between caffeine and cognitive 
abilities in older adults, and adopted by many researchers, is that regular caffeine 
consumption enhances the neuroprotective actions of adenosine. Like alcohol, caffeine 
readily crosses the blood-brain barrier. It is well documented that, once in the brain, caffeine 
acts as an antagonist on the A2a adenosine receptors. By counteracting adenosine, caffeine has 
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a disinhibitory effect, causing the stimulation of cholinergic neurotransmitters (8). These 
neurotransmitters exert a protective effect against β-amyloid induced neurotoxicity, a 
precursor to cognitive decline in humans (9) and in mice (10). Caffeine, especially coffee, is 
rich in biologically active substances such as polyphenols and antioxidants and is capable of 
increasing plasma antioxidant capacity in humans (11). Therefore, another potential 
physiological mechanism by which caffeine may afford some protection against brain aging, 
is by counteracting the oxidative stress involved in the pathogenesis of aging related diseases. 
Another risk factor for cognitive decline is type II diabetes (12). A systematic review of 
several large scale prospective studies (13) supported the hypothesis that habitual coffee 
consumption is associated with a substantially lower risk of type II diabetes. Others have 
reported protective effects of long-term caffeine intake on the risk of developing Alzheimer’s 
disease (14, 15). Coffee drinkers are reported to have a 30% lower risk of developing 
Parkinson’s disease (16). 
 
In recent years, evidence has generally supported the assertion that caffeine intake 
(particularly from coffee) may help to maintain cognitive functions in aging. Some 
longitudinal studies have documented an inverse association between coffee consumption and 
cognitive decline. In a men-only study, Gelder et al. (17) found that, among the elderly, those 
who drank coffee had half the 10-year cognitive decline than non coffee drinkers. The least 
decline occurred for men consuming three cups of coffee per day. Others have reported 
gender-specific benefits of caffeine on cognitive function favoring women. In a large 
prospective study, women who drank more than three cups of coffee per day showed less 
decline in verbal cognitive functioning and visuospatial memory over a four year period than 
women who had low or no consumption of coffee (18). However, no effect was observed in 
men. Similarly, Johnson-Kozlow et al. (19) reported that lifetime and current exposure to 
coffee was associated with better cognitive performance among women, but not in men. 
Female coffee drinkers (especially those aged 80 and over) performed better on cognitive 
tasks of memory, attention and concentration. Although men consumed more caffeine than 
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women per day, they hypothesized that women are more sensitive to the pharmacological 
effects of caffeine than men.  
 
However, some have investigated the relationship between caffeine and cognitive abilities 
with inconsistent results. Van Boxtel et al. (20) found no significant reduction in age related 
cognitive decline with habitual caffeine intake (from tea and coffee) after 6 years and 
concluded that the longitudinal effect of caffeine is limited at best. Methodological 
differences may, in part, account for the discrepancies between studies. Tea and coffee 
consumption is frequently measured as ‘number of cups consumed daily’, whereas others 
measure caffeine intake based on standard estimations of caffeine per cup of coffee or tea. 
However, caffeine content can vary markedly between different types of beverages. One cup 
of instant coffee can contain between 21mg and 120mg of caffeine, whereas the equivalent 
serving size of ground coffee (filter, espresso, etc.) can contain up to 254mg (21). Assuming 
that every cup of coffee contains an equivalent level of caffeine is unlikely to give an accurate 
reflection of caffeine intake. Few studies have included tea consumption in their 
investigations and no other study, as far as we are aware, has included the effects of overall 
dietary caffeine exposure on cognitive function, especially in old age.  
 
Attempting to measure the effects of caffeine (or any variable for that matter) on cognitive 
abilities in old age is problematic without some measure of prior cognitive ability as a 
baseline comparison. If there is a significant association in a group of older people between, 
say, caffeine intake and cognitive ability, this does not necessarily mean that caffeine is 
beneficial for cognitive abilities in old age. One of the limitations of most studies in the field 
of cognitive aging is the possibility of reverse causation; that is, the supposed dependent 
(outcome) variable might be causing changes in the supposed independent (predictor) 
variable. It is possible that early life intelligence influences caffeine intake as well as vice 
versa. Indeed, it is well demonstrated in large, population-representative samples that 
childhood IQ influences many aspects of diet and health-related lifestyle (22). The Lothian 
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Birth Cohort 1936 is almost unique in terms of having a measure of IQ at both childhood (age 
11) and later life (age 70) in addition to multiple cognitive domain scores and demographic 
and health data from late life. This dataset is in an ideal position to provide an insight into the 
associations, if any, between caffeine intake and cognition in older people. The aim of the 
present study was to examine the association between caffeine consumption (coffee, tea and 
additional sources) and performance on a comprehensive battery of cognitive function tests in 
a sample of older adults (aged about 70) from the Lothian Birth Cohort 1936 Study, whilst 
controlling for prior cognitive ability (age 11 IQ). Cognitive assessment at age 70 included 
multiple markers of memory, speed of information processing, general cognition and verbal 
intelligence. Focussing on these specific cognitive domains may help to untangle the effects 
of caffeine on cognitive performance in older adults. 
 
METHODS 
Participants and general methods 
The participants were surviving participants of the Scottish Mental Survey of 1947 
(SMS1947: 23). The SMS1947 tested the mental ability of almost all Scottish schoolchildren 
born in 1936 and attending school on June 4th 1947 (aged 11), using a well-validated test of 
general intelligence: a version of the Moray House Test No. 12. The 1091 surviving 
participants described in the present study are known as the Lothian Birth Cohort 1936 
(LBC1936). Full details of the recruitment and testing of the LBC1936 are given in a free-
access protocol paper (24). At the time of recruitment, LBC1936 members mostly resided in 
Edinburgh and its surrounding area (Lothian) in Scotland. They were relatively healthy and 
lived independently. Between July 2004 and May 2007, at a mean age 69.5 years, each 
LBC1936 participant attended the Wellcome Trust Clinical Research Facility at the Western 
General Hospital in Edinburgh to undergo extensive cognitive and physical testing and an 
interview. Cognitive assessments were conducted by trained researchers and physical testing 
was carried out by research nurses. The standardized interview ascertained demographic 
information, smoking and alcohol consumption, medical history, and medication use. As a 
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part of their general assessment, LBC1936 participants were asked to complete the Scottish 
Collaborative Group 165-item Food Frequency Questionnaire (25). Ethics permission for the 
Lothian Birth Cohort 1936 (LBC1936) study protocol was obtained from the Multi-Centre 
Research Ethics Committee for Scotland (MREC/01/0/56) and from Lothian Research Ethics 
Committee (LREC/2003/2/29). The research was carried out in compliance with the Helsinki 
Declaration. All participants gave their written, informed consent. 
  
Procedure 
Measurement of caffeine intake 
Caffeine intake was assessed using the Scottish Collaborative Group Food Frequency 
Questionnaire (FFQ) version 7.0. (26). The FFQ has been found to have good repeatability 
(dietary intake in later life is reasonably stable in the short term) and good validity for most 
nutrients in community dwelling older populations (27, 28). This self-report questionnaire 
comprises questions about dietary intake over the previous 2-3 month period and is designed 
to estimate daily intake of a wide range of nutrients. The FFQ measures intake of caffeine 
from the main dietary sources, namely: ‘instant coffee’ (freeze-dried), ‘filter, espresso or 
cappuccino coffee’ (hereby collectively referred to as ‘ground coffee’), ‘decaffeinated 
coffee’, ‘tea (regular)’, ‘herbal, fruit or decaffeinated tea’, ‘diet fizzy drinks (cola, lemonade 
etc)’, ‘regular fizzy drinks’, ‘hot chocolate’, ‘Horlicks or Ovaltine’, ‘mousse, blancmange, 
trifle, meringue’, ‘chocolate bars (e.g. Mars, Dairy Milk)’, ‘chocolate sweets, toffees or 
fudge’, ‘chocolate coated biscuits’, ‘peanut butter or chocolate spread’. Each item on the 
questionnaire refers to a standard measure, e.g., 1 cup or mug (hot drinks), 1 biscuit, 1 can 
(fizzy drinks). Participants mark one of nine responses to indicate frequency of consumption 
of the measure: rarely or never; 1-3 per month; 1 per week; 2-3 per week; 4-6 per week; 1 per 
day; 2-3 per day; 4-6 per day; 7+ per day.  
 
The FFQ was given at the clinic visit and returned in a stamped addressed envelope. In the 
event of any missing responses, a letter was sent requesting the information. If there were 
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more than 10 missing items (even after a letter had been sent) the FFQ was labelled 
‘incomplete’ and excluded from the analyses. 929 participants (85%) returned completed 
(<10 missing items) questionnaires (51.6% by women). 97 were not returned, 26 were 
returned blank, 39 were incomplete. One ‘completed’ questionnaire had several missing 
caffeine containing items and was excluded. Five further individuals were excluded because 
they were identified as having potential dementia based on a score of <24 on the Mini-Mental 
State Examination (29). Therefore, the final sample for analysis in the present study 
comprised 923 relatively healthy participants (446 men, 477 women) aged about 70 (m = 
69.5, sd = 0.8) years at time of testing. 
 
The amount of caffeine (coded as milligrams daily) estimated to be present in each item was 
calculated using a caffeine composition database compiled from British beverage and food 
caffeine surveys, where caffeine levels were obtained using validated analytical techniques 
(30, 21, 31, 32, 33, 34, 35). Estimated average caffeine values were assigned to each food or 
drink including (per 1 cup or mug serving): tea (34.2mg), instant coffee (43.7 mg) and ground 
coffee (93.1mg). A measure of ‘total caffeine’ consumption was derived from all 14 caffeine 
containing items in the FFQ. In order to investigate the effect of overall coffee intake, because 
this is often used in the previous literature, an additional measure of ‘total caffeine from 
coffee’ was derived by combining consumption of both instant coffee and ground coffee.  
 
Measurement of cognitive performance at age 70 
A full description of the cognitive tests and administration procedures used can be found in 
the free-access LBC1936 protocol article (24). Cognitive testing was carried out by a trained 
researcher. Brief descriptions of the tests follow. 
The Mini-Mental State Examination (MMSE) was used as a screening measure for 
cognitive pathology (29). Scores range from 0-30, with a score of less than 24 indicating 
possible dementia. 
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From the Wechsler Adult Intelligence Scale-IIIUK (WAIS-III: 36) we included: Digit 
Symbol Coding (speed of information processing); Block Design (constructional ability); 
Matrix reasoning (non-verbal reasoning); Digit Span backwards (working memory); Symbol 
Search (speed of information processing); Letter-number sequencing (working memory). 
From the Wechsler Memory Scale-IIIUK (WMS-III: 37) we used: Logical Memory I 
and II (verbal declarative memory, immediate and delayed recall); Verbal Paired Associates I 
and II (verbal learning and memory, immediate and delayed recall); Spatial Span (non-verbal 
spatial learning and memory).  
Verbal Fluency (phonemic) provides a measure of executive function (38). National 
Adult Reading Test (NART: 39) and Wechsler Test of Adult Reading (WTAR: 40) are widely 
used to estimate prior cognitive ability and they require the pronunciation of irregular words. 
Simple and Four-choice reaction time measure speed and variability of simple information 
processing, using a purpose built portable machine (41, 42). Inspection time is a computer-
based task used to assess speed of elementary visual processing (43). 
 
Demographic and control variables, including childhood IQ 
Demographic and medical information was obtained at the clinic assessment. During the 
standardized interview, participants were asked questions relating to their marital status, 
education (number of years of full time [F/T] education), current alcohol consumption (type 
and frequency, from which units per week were calculated), and smoking status (current, ex 
or never smoker). Social class was derived from participants’ highest reported occupation 
(44) and consisted of 6 categories ranging from I (professional occupations) to V (unskilled 
occupations), with III (skilled occupations) divided into IIIN (non-manual) and IIIM 
(manual). The women in the cohort were asked for their husband’s occupation as well as their 
own, and assigned a social class based on the highest occupation of the household. This was 
derived from their own occupation for about half of the women, and from their husband’s 
occupation for the remainder. Social class is here represented in a numeric fashion with 
classes IIIN and IIIM expressed as 3 and 3.5 respectively to reflect their relative status. A 
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detailed medical history was taken (including diagnoses of diabetes, high blood pressure, and 
high cholesterol). Anxiety and depression symptoms were assessed using the Hospital 
Anxiety and Depression Scale (HADS). This is a short self-assessment scale consisting of 7 
items for anxiety and 7 for depression. A physical examination was performed by a nurse 
including measurements of height and weight, from which body mass index (BMI) was 
calculated. Participants completed a 20-page questionnaire booklet containing various social 
and lifestyle questionnaires and measures of physical activity (including number of days per 
month of exercise).  
 
Age 11 scores were obtained, in collaboration with the Scottish Council for Research in 
Education (SCRE) and with the permission of LBC1936 participants, from the original 
Scottish Mental Survey of 1947 (SMS1947) records. The Moray House Test (MHT) No.12 
was taken by participants in the SMS1947 at age 11 (45) and repeated at their clinic visit aged 
about 70. MHT scores were corrected for age in days at time of testing and converted to 
standard IQ type scores where mean = 100 and sd = 15. This is a well-validated general 
mental test comprising 71 items (mostly verbal reasoning, but also some numerical, spatial 
and other items) with a maximum score of 76 and a 45-minute time limit.  
 
Statistical analyses 
Demographic and health differences between tertiles of caffeine intake groups were examined 
using ANOVA, Chi-Square and t-tests as appropriate. Tertiles of consumption were used for 
illustration purposes only; the main analyses were conducted using caffeine as a continuous 
variable. Associations between caffeine consumption (derived from total caffeine, tea, instant 
coffee, ground coffee and total coffee) and cognitive function were examined using univariate 
general linear models. Four models were fitted to the data, each including adjustment for 
potential confounding factors. The base model included age (in days at time of testing) and 
sex. The second model included age, sex, and occupational social class. A third model 
included age, sex, and age 11 IQ to control for early life cognitive ability. In the fourth and 
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final model, all four control variables were included. A general cognitive ability component 
score (g factor) was derived from principal components analysis (PCA) of six WAIS-III 
subtests (Letter-number sequencing, Matrix reasoning, Block design, Digit symbol, Digit 
Span backwards, Symbol search). A general processing speed component score (speed) was 
similarly derived from a PCA of the set of speed measures (Symbol search, Digit symbol, 
Simple RT mean, Choice RT mean, Inspection time). The extraction of these factors by PCA 
has been described elsewhere (46). Using the same method, a general memory factor 
(memory) was extracted from the WMS-III subtests (Logical memory I immediate and II 
delayed recall, Spatial span forwards, Spatial span backwards, Verbal paired associates I 
immediate and II delayed recall) and two WAIS-III subtests (Letter-number sequencing, Digit 
Span backwards). The fourth cognitive outcome variable used in the present study is age 70 
IQ (Moray House Test score at age 70 corrected for age in days at time of testing and 
converted to an IQ scale where mean = 100 and sd = 15). Additional analyses were performed 
with NART and WTAR scores (measures of verbal IQ) as cognitive outcomes. We present 
estimates of effect size as well as p values. 
 
RESULTS 
The characteristics of study participants are presented in Table 1 by tertile of total caffeine 
consumption; low caffeine (1.2 – 131.0 mg/day); medium caffeine (131.0 – 211.0 mg/day); 
high caffeine (211.0mg – 701.1 mg/day). Of the 923 participants who provided caffeine data, 
data from 16 cells were incomplete (no more than 1 incomplete caffeine item per person). 
Analyses were conducted on caffeine data from all 923 FFQs; however, total caffeine was 
calculated only where data were complete (n = 907). High caffeine consumers were 
significantly less likely to have had a diagnosis of high blood pressure (p < .001), diabetes (p 
= .005) or cholesterol (p = .008) than low caffeine consumers. Medium caffeine consumers 
were significantly less likely to have had a diagnosis of high blood pressure (p = .04) or 
diabetes (p = .03) than low caffeine consumers. Level of caffeine consumption was not 
significantly associated with any other demographic variable. Non-responders to the FFQ 
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(where questionnaires were not returned or returned blank, n = 123) were significantly more 
likely to be men than women (n = 74 vs. 49, χ2 (1) = 5.47, p = .02), have less years of full 
time education (m = 10.52 vs. 10.77, p = .02) and lower MMSE scores (m = 28.3 vs. 28.9, p < 
.001) than responders. Responders and non-responders differed significantly in their smoking 
status (χ2 (2) = 6.192, p = .04).  
[TABLE 1 about here] 
 
Total caffeine: Mean total caffeine intake (per day) from all dietary sources was 182.5mg, 
and ranged from 1.2mg to 701.1mg (see table 2). Caffeine intake (mean) was slightly higher 
in women (187.9mg) than men (176.8mg) although this difference was non-significant. 
[TABLE 2 about here]  
Caffeinated tea/coffee: Coffee and tea consumption in this Scottish cohort was widespread. 
97.7% of participants reported consuming caffeinated tea or coffee in the last 2-3 months. 21 
participants (2.3%) reported that they ‘rarely or never’ drank caffeinated tea or coffee. Of the 
total sample, 85.5% consumed tea, 72.0% consumed instant coffee and 49.0% consumed 
ground coffee (see table 2 for a breakdown by gender). Women consumed significantly more 
ground coffee than men; otherwise, there were no statistical differences between the 
consumption of different types of caffeinated tea or coffee by gender. Beverage preference 
did not appear to be exclusive; 84% of the sample drank both tea and coffee. However, as 
expected, there was a significant negative correlation between tea and coffee consumption (-
.28, p < .001) suggesting that heavy consumers of tea tend to drink little coffee and vice versa. 
 
Decaffeinated tea/coffee: Men and women differed significantly in their consumption of 
decaffeinated tea and coffee. Compared to men, women had a significantly higher mean 
intake of decaffeinated tea (p <.001) and decaffeinated coffee (p =.001) (data not presented). 
In this older cohort, consumption of decaffeinated coffee and herbal tea was insufficient to 
warrant inclusion in the analyses as separate measures of caffeine consumption. Although 
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they contribute relatively small amounts of caffeine to the diet and are consumed by less than 
a quarter of our sample, they are included in the ‘total caffeine’ measure (see table 2).  
 
Caffeine consumption, age 11 IQ and social class 
Age 11 IQ and social class were identified as potential confounding variables of an 
association between caffeine intake and cognitive ability at age 70. There were significant 
positive correlations between age 11 IQ score and caffeine from ground coffee and total 
coffee, and a significant negative correlation with tea (see table 2). There were significant 
negative correlations between social class group (where a lower number indicates a more 
professional occupation) and total caffeine, caffeine from ground coffee, total coffee, 
decaffeinated coffee and herbal/other tea and a significant positive correlation with tea. There 
was a general trend for increasing (caffeinated) tea consumption in the lower social class 
groups and those with lower age 11 IQ scores; and there was generally higher coffee 
consumption in higher social class groups and those with higher age 11 age scores.    
 
Caffeine consumption and cognitive performance at age 70 
Table 3 displays the results of four univariate general linear models for each cognitive 
outcome variable. Examination of models including appropriate interaction terms revealed no 
significant effects of caffeine by gender. Results are therefore not differentiated by gender 
below, and interactions were not included in the final models. 
[TABLE 3] 
 
The overall caffeine measure ‘total caffeine’ was significantly and positively associated with 
memory (in the base model only) and with age 70 IQ, NART and WTAR in the base model 
and model 3 (with age 11 IQ) but not after social class adjustment or in the fully adjusted 
model. Caffeine from tea had a significant, inverse association with age 70 IQ, g factor, 
processing speed, NART and WTAR scores in model 1 (sex and age adjusted, p <.01) and 
model 2 (sex, age and social class adjusted, p <.05). However, when age 11 IQ was added (as 
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in models 3 and 4) all significant associations fell to non-significant levels. The memory 
factor was not found to be associated with this caffeine measure. Results indicated no 
relationship between caffeine from instant coffee and cognitive test scores at age 70 at any 
stage in the analyses. Caffeine from ground coffee was significantly associated with better 
performance on all age 70 cognitive measures (age 70 IQ, g factor, processing speed, 
memory, NART and WTAR, p < .001) but this was found in the baseline model only, with 
the exception of processing speed, NART and WTAR. The association with processing speed 
was attenuated with the addition of age 11 IQ then declined to non-significant levels when 
social class was included (models 2 and 4). The association with NART and WTAR scores, 
however, not only retained significance when controlling for age 11 IQ but survived full 
adjustment for all covariates (p = .007 and p = .02, respectively). Additional adjustment for 
years of full-time education further attenuated this association but did not remove it (p = .02, 
ηp
2 = .006; p = .04, ηp2 = .005, respectively). Education correlates strongly with age 11 IQ in 
this sample (.382, p<.001) and explains less of the variance in age 70 IQ than age 11 IQ. For 
this reason, we do not present the results using education as a confounder. Caffeine from total 
coffee (a measure often used in the literature) had a significant, positive association with all 
age 70 cognitive measures using the base model (p < .001). Unlike caffeine derived from 
ground coffee only, the associations between this combination coffee measure and all five 
cognitive outcome variables, remained significant when controlling for social class. However, 
these associations were either attenuated (processing speed, NART) or declined to non-
significance once age 11 IQ scores are included in the model. None of the associations 
survive the fully adjusted model. 
 
DISCUSSION 
The results provide limited support for a positive effect of caffeine consumption on cognition 
in later life. There are three main results of interest. First, after adjustment for childhood IQ, 
most of the ‘protective’ effects of caffeine on cognition are removed. Previous studies 
reporting beneficial effects of caffeine (or coffee) consumption on cognitive function in old 
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age have been unable to control for prior ability. IQ is relatively stable over time (47, 48). In 
this sample, the correlation between age 11 and age 70 IQ is .66 (p < .001), supporting the 
assertion that childhood IQ accounts for the majority of variance in later life cognition. The 
remaining variance is accounted for by factors other than caffeine intake. With full 
adjustments for age, sex, social class and age 11 IQ, we found no protective effects of 
caffeine consumption on performance on memory, speed of information processing or general 
cognition component scores and on the MHT (a general intelligence test) at age 70.  
 
Second, the only indication that caffeine consumption exerts a protective influence on 
cognitive performance was that drinkers of ground (filter and espresso type-) coffee 
performed better on tests of verbal intelligence (NART and WTAR) than non drinkers of 
ground coffee even when controlling for age 11 IQ and social class. Performance on these 
tests is widely assumed to reflect prior cognitive ability and level of education. Indeed, highly 
significant, positive correlations exist between age 11 IQ and NART and WTAR scores (.66, 
p <.001; .64, p <.001 respectively) in this population. For this reason, it was initially 
surprising that there remained a beneficial effect of ground coffee intake on performance on 
these tests, once age 11 IQ has been controlled for. However, NART and WTAR are thought 
to capture peak prior adult cognitive ability. Perhaps the association between ground/espresso 
coffee drinking and NART and WTAR is still significant after adjusting for age 11 IQ 
because they capture variance related to intellectual development and its associated education 
and lifestyle choices between childhood and adulthood. 
 
Third, even before controlling for age 11 IQ, no gender effects were found, contrary to 
previous studies. Many have reported effects of caffeine on cognition in women, but not men. 
However, patterns of consumption differ widely as a result of cultural habits. Much of the 
caffeine research reporting gender effects comes from cohorts in the Netherlands and Finland 
which are known for being heavy caffeine (predominantly coffee) consumers with an average 
daily caffeine intake of 400mg per day in both men and women (49).The results of these 
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studies may not be generalisable to the UK where survey data reveals average consumption to 
be a more moderate 240mg a day. The Bristol Dietary Caffeine and Health Study surveyed 
5870 British adults and found that caffeine intakes were significantly higher in men 
(263mg/day) than in women (226mg/day) (50). However, in the present study, the average 
age was older at 70. Mean daily caffeine intake was lower (182mg per day) than the UK 
average and comparable in men and women. This is not surprising given that caffeine 
(especially coffee) intake decreases with age, especially after about 65. Coffee has 
significantly higher concentrations of caffeine and more stimulating effects than tea. Since 
there is a greater sensitivity to the effects of caffeine in older people, tea may become the 
beverage of choice. Perhaps any prior difference in caffeine consumption (and its effects) by 
gender disappears with increasing age. It is nevertheless surprising that, given the very narrow 
age range in this cohort (all born in 1936), there was a (non-significant) trend for the high 
caffeine consumers to be younger than both medium and low caffeine consumers.  
 
Throughout the models, there was a general trend for individuals who drink more coffee and 
less tea to have better cognitive health at age 70, but these effects were not borne out 
statistically by our analyses. Previous studies have attributed the opposing effects of tea and 
coffee on health outcomes, either to differing ‘pharmacological’ effects of tea and coffee or to 
lifestyle or socio-economic differences between the consumers of these beverages (51, 52). In 
Scotland, research suggests that coffee drinking is associated with higher socio-economic 
status (SES) and good health whereas drinking tea is associated with lower SES and poorer 
health outcomes (53). The present study supports (in part) these research findings; in the 
LBC1936, tea consumption was higher in the ‘lower’ social classes whereas those who drink 
coffee were more likely to belong to the ‘higher’ social classes. However, the more important 
confounder in this study was age 11 IQ (with some contribution from social class). The 
results of the general linear models suggest that it is age 11 IQ which is driving most of the 
associations with performance on cognitive tasks at age 70. Individuals with a high childhood 
IQ at age 11 were more likely to continue to perform better into adulthood than those with a 
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lower age 11 IQ irrespective of their caffeine intake. Age 11 IQ was also predictive of tea or 
total coffee intake in late life; higher IQ children were more likely to drink coffee, while 
poorer performance on the age 11 test was linked with a preference for tea some 60 years 
later. These findings suggest a bidirectional relationship between type of caffeine intake and 
IQ.  
 
We conducted a post-hoc mediational analysis (Sobel test), in order to examine the extent to 
which the age 11 IQ and coffee intake at age 70 association is mediated by social class. The 
standardized beta of the direct path (age 11 IQ-ground coffee consumption) was 0.132, and 
0.054 after social class was introduced as a mediator. The amount of the relationship between 
age 11 IQ and ground coffee consumption, accounted for by social class as a mediator, was 
.08; this represents 59.1% of the direct effect (z = 5.27, p <.001). Rather than suggesting a 
causal link between early life ability and adult tea or coffee preference, the results may reflect 
the fact that those individuals with a higher childhood IQ are more likely to achieve a higher 
SES and may, therefore, be more represented in social groups that choose to follow a lifestyle 
which is more ‘cosmopolitan’. This would be reflected in social and dietary preferences. 
Coffee drinking, in the UK, is associated with an urban lifestyle among both young and older 
educated individuals. Therefore, the association between adult cognitive ability and tea and 
coffee consumption may simply be reflecting lifestyle preferences which vary with IQ/SES. 
 
Further support for this alternative explanation may arise from the finding that caffeine 
consumption in our cohort was associated with a range of health outcomes also associated 
with cognitive decline. We found less evidence of markers of ill health in the high caffeine 
group than the low caffeine group. Men and women with the highest consumption of caffeine 
were less likely to have ever had diabetes, high blood pressure and high cholesterol than those 
drinking less caffeine. This contradicts prevailing medical opinion that caffeine has adverse 
effects on health but supports, to a certain extent, the findings of the Scottish Heart Health 
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Study (53); they reported that in Scotland, coffee drinking was associated with a reduction in 
coronary risk factors, coronary risk and mortality and the converse was true of tea.  
 
One of the advantages of this study is that we have used a uniformly older cohort who share 
the same year of birth. We were able to control for a range of demographic variables which 
have previously been related to caffeine intake. Second, we were able to investigate the 
effects of drinking different types of coffees as well as measuring total caffeine consumption 
from a wide variety of dietary sources, not just tea and coffee. Third, using general cognitive 
factors (extracted from the large cognitive test battery), we were able to investigate the effects 
of caffeine on different aspects of cognitive function. Fourth, we had a measure of childhood 
IQ. There will be opportunities for follow-ups of this cohort offering the potential to 
investigate caffeine’s effects on cognitive decline. 
 
Selective attrition could have contributed to a healthy survivor effect. One potential limitation 
of the study is that the sample represents a healthy and high functioning sub-group of the 
Scottish Mental Survey 1947 cohort. Our sample achieved higher mean age 11 IQ scores (m = 
50.02, sd = 11.04) than the original cohort (m = 36.74, sd = 16.10) and this may have 
restricted the range of cognitive outcome scores. That said, the range of age 11 IQ scores in 
the sample was large. The most likely result of this is some small underestimation of effects 
sizes of the associations. Further limitations of the study concern the measurement of 
caffeine. FFQ responses reflect the previous 2-3 month period only. Current intake was 
assumed to be representative of habitual intake as diet (including tea and coffee consumption) 
is likely to remain stable over time (barring illness, of course). Even so, we cannot exclude 
the possibility that some people may have significantly altered their caffeine intake following 
a diagnosis or period of bad health. Medical advice often dictates that coffee intake should be 
kept to a minimum, especially in the presence of high blood pressure and vascular problems. 
 
 18 
 
Caffeine levels in this study are estimations only, based on the best available government 
survey data and are not comparable to the experimental caffeine studies which are laboratory 
based. Using estimated measures of caffeine content in drinks is problematic. Caffeine intake 
estimates may be limited by the high variability in caffeine composition of foods and 
beverages. In theory, ground coffee has a higher caffeine content than instant coffee and 
making this distinction during data collection is important. However, a weak ground coffee 
may be equivalent in caffeine strength to a strong instant coffee. The effects found in this 
Scottish sample may not be generalizable to other populations. Tea drinking is the norm in the 
UK where there is a higher annual per capita tea consumption than any other country. Even 
by today’s standards, drinking filter and espresso coffee is associated with an educated, 
middle class lifestyle. In many other countries, consumption of strong, ground coffee is 
ubiquitous and independent of social position. Although coffee drinking in the UK is 
associated with SES, the mediation analysis, which found that childhood IQ explains more of 
the variance in adult cognitive ability than social class, provides a clear locus in the present 
study's findings where there are implications beyond the UK setting. 
 
CONCLUSIONS 
The present study provides little evidence that caffeine consumption has protective effects on 
cognitive function at age 70. It would appear that childhood IQ and other factors including 
social class, rather than caffeine intake, are driving the association with later life cognition. 
This study places childhood IQ and social class firmly within the framework of the diet-
cognition relationship and raises doubts about the hypothesized causal effects of long-term 
caffeine consumption as a protective factor against cognitive decline in later life. However, 
there may be some residual benefit of drinking ground coffee (typically the stronger types of 
coffee often consumed in cafes and restaurants) on verbal IQ, irrespective of prior ability. 
While these associations are interesting, the contribution of caffeine is very small in relation 
to other intervening factors. Before advocating the benefits of coffee on cognitive health and 
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general well-being, further research is needed to fully understand the nature of these 
associations and rule out chance confounding by other factors. 
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TABLE 1. Characteristics of the study population by category of daily caffeine 
consumption (mean values and % prevalence) 
  Total sample Low caffeine Medium caffeine High caffeine  
  N = 923* N = 302 N = 303 N = 302  
  Mean sd Mean sd Mean sd Mean sd   p  
Caffeine (mg/day)  182.5 97.8 85.5 34.3 175.0 22.8 287.2 81.1  
Age (in years)  69.5 0.84 69.6 0.83 69.5 0.85 69.4 0.84 .30 
Sex          .24 
  Male (%)  48.3  51.0  50.2  44.7   
  Female (%)  51.7  49.0  49.8  55.3   
Marital status          .10 
  Married (%)  72.4  67.9  72.3  77.2   
  Widowed (%)  13.3  14.9  14.1  10.9   
  Unmarried/divorced (%)  14.2  16.9  13.5  11.8   
Education (yrs f/t)  10.8 1.2 10.7 1.1 10.8 1.1 10.9 1.3 .10 
MMSE  28.9 1.2 28.8 1.3 29 1.2 29 1.2 .18 
Alcohol consumption 
(units/wk) 
 
 
10.6 14.3 11.6 18.2 9.9 12.2 10.1 11.4 .27 
Body Mass Index (kg/m2)  27.6 4.3 28.1 4.1 27.4 4.1 27.4 4.5 .08 
Physical activity (days/mth)  7.5 8.0 7.0 7.6 8.0 8.2 7.7 8.3 .33 
Smoking status          .29 
  Non-smokers (%)  44.4  43.0  47.5  42.1   
  Ex-smokers (%)  43.2  47.0  40.6  43.0   
  Current smokers (%)  12.4  9.9  11.9  14.9   
Hypertension, yes (%)  39.5  47.0  38.6  33.1  .002 
Diabetes, yes (%)  7.5  11.3  6.3  5.0  .008 
Cholesterol, yes (%)  35.1  39.7  35.8  29.5  .03 
 28 
 
 
*Full study sample comprises 923 men and women. Due to some missing caffeine data, 16 
subjects have no total caffeine measure and therefore not included in the tertiles of 
consumption 
Abbreviations: sd, standard deviation; MMSE, Mini-Mental State Examination 
p values are from t-tests, ANOVA and chi-square tests as appropriate 
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TABLE 2.  Caffeine consumption in men and women (median values, ranges and p values) and correlations with age 11 IQ and social class 
 
 Total sample 
N = 923 
 
 
Men 
N = 446 
 
 
Women 
N = 477 
 
 
 Age 11 IQ Social class 
       Mann-Whitney 
U 
Spearman rho Spearman rho 
Caffeine (mg per day) Median (range) % 
reporting 
Median (range) % 
reporting 
Median (range) % 
reporting 
     U         (p)   rs     (p)  rs      (p) 
Total caffeine (all sources)* 177.5 (0-701.1)  175.7 (1.2-563.2)  178.1 (7.0-701.1)  97406.5    (.18)  .053  (.12) -.098  (.003) 
Caffeine from tea (regular) 85.5   (0-256.5) 85.5 85.5   (0-256.5) 87.6 85.5   (0-256.5) 83.4 103064.5  (.47) -.113  (.001)  .067  (.04) 
Caffeine from instant coffee 43.7   (0-327.8) 72.0 43.7   (0-327.8) 75.2 31.0   (0-327.8) 68.8 98315.5    (.08)  .034  (.32)  .042  (.21) 
Caffeine from ground 
coffee  
0        (0-698.3) 49.0 0        (0-465.5) 44.6 6.5     (0-698.3) 52.6 97022.0    (.01)  .236  (<.001) -.277  (<.001) 
Total caffeine from coffee  50.2   (0-698.3)  50.2   (0-465.5)  50.2   (0-698.3)  104849.0  (.92)  .159  (<.001) -.154  (<.001) 
 
* Due to some missing caffeine data, 16 subjects have no total caffeine measure  
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TABLE 3. Associations between caffeine intake and cognitive outcomes. General linear models, p values and associated partial eta squared values 
      Model 1: sex + age; Model 2: sex + age + social class; Model 3: sex + age + age 11 IQ; Model 4: sex + age + age 11 IQ + social class 
Predictor  *Age 70 IQ g factor processing speed memory NART WTAR 
  N = 919  N = 909 N = 887 N = 893 N = 923 N = 923 
mg per day Model  p ηp2  p ηp2  p ηp2  p ηp2  p ηp2  p ηp2 
Total caffeine 1 .03 a .005 .05 .004 .27 .001 .02a .007 .01 a .007 .02 a .006 
(all sources) 2 .35 .001 .47 .000 .93 .000 .13 .003 .29 .001 .33 .001 
 3 .04 a .005 .14 .003 .36 .001 .05 .004 .02 a .007 .02 a .006 
 4 .12 .003 .44 .000 .90 .000 .11 .003 .14 .003 .16 .002 
              
Caffeine from 1 <.001b .012 <.001b .014 .001b .013 .20 .002 .002 b .011 .007 b .008 
tea 2 .006 b .008 .003 b .010 .002 b .011 .39 .000 .01 b .007 .03 b .005 
 3 .62 .000 .26 .001 .08 .004 .37 .000 .68 .000 .97 .000 
 4 .74 .000 .30 .001 .06  .004 .38 .000 .70 .000 .99 .000 
              
Caffeine from 1 .07 .004 .30 .001 .16 .002 .29 .001 .94 .000 .98 .000 
instant coffee 2 .06 .004 .25 .002 .21 .002 .28 .001 .80 .000 .93 .000 
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 3 .19 .002 .78 .000 .34 .001 .75 .000 .31 .001 .25 .002 
 4 .21 .002 .72 .000 .39 .001 .73 .000 .42 .000 .29 .001 
              
Caffeine from  1 <.001 a .014 <.001 a .017 <.001 a .001 <.001 a .014 <.001 a .033 <.001 a .028 
ground coffee 2 .15 .002 .08 .003 .06 .004 .05  .004 .002 a .011 .005 a .009 
 3 .20 .002 .05  .004 .03 a .006 .11 .003 <.001 a .018 <.001 a .014 
 4 .49 .000 .38 .000 .16 .002 .25 .002 .007 a .008 .02 a .007 
              
Total caffeine 1 <.001 a .018 <.001 a .016 <.001 a .015 <.001 a .014 <001 a .021 <.001 a .017 
from coffee 2 .01 a .007 .03 a .005 .02 a .006 .02 a .006 .008 a .008 .02 a .006 
 3 .05  .004 .08 .003 .02 a .007 .14 .003 .01 a .007 .05  .004 
 4 .15 .002 .34 .001 .09 .004 .24 .002 .12 .003 .26 .002 
 
*Age 70 IQ is already age-adjusted (age not included in the models for this outcome variable) 
a denotes a positive model correlation coefficient 
b denotes a negative model correlation coefficient  
 
 
